# 18F-FluorThanatrace (PET/CT) in Glioblastoma

> **NCT04221061** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 3 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** 18F-FluorThanatrace

## Key facts

- **NCT ID:** NCT04221061
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-20
- **Primary completion:** 2024-06-10
- **Final completion:** 2024-06-10
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Companion treatment trial closed early with negative results. No imaging study participants completed the full study imaging planned due to logistical difficulties.
- **Last updated:** 2024-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04221061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04221061, "18F-FluorThanatrace (PET/CT) in Glioblastoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04221061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*